THE EPOCH TIMES – Health Secretary Robert F. Kennedy Jr. said in a new interview that Novavax’s COVID-19 vaccine is not effective, his first comments since regulators missed a deadline to approve the shot.
“We’re looking at that vaccine. It is a single antigen vaccine, and for respiratory illnesses, the single antigen vaccines have never worked,” Kennedy told CBS in an interview released on April 9.
The Food and Drug Administration (FDA) was supposed to decide whether to grant Novavax’s license application by April 2, the Maryland-based company has said.
The firm makes one of the three COVID-19 vaccines available in the United States, and the only one that does not use messenger ribonucleic acid technology.
The FDA has not said why the deadline passed without a decision.
An official with the Department of Health and Human Services (HHS), which Kennedy heads, previously told The Epoch Times in an email that “any delays to the FDA’s independent review process for the Novavax are a result of scientific review to ensure safety and efficacy.” The FDA is part of HHS.
Novavax shares dropped from $6.95 on April 9 to $5.12 on April 10, though the price had partially rebounded to $5.61 on Friday …
